medigraphic.com
ISSN 0035-0052 (Print)

2017, Number 3

Next >>

Rev Mex Pediatr 2017; 84 (3)

Kawasaki disease: pediatrician role after diagnosis

López-Madrigal F

Language: Spanish
References: 14
Page: 83-87
PDF size: 251.11 Kb.


Text Extraction

No abstract.


REFERENCES

  1. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017; 135(17): e927-e999.

  2. Wang CL, Wu YT, Liu CA, Kuo HC, Yang KD. Kawasaki disease: infection, immunity and genetics. Pediatr Infect Dis J. 2005; 24(11): 998-1004.

  3. Diagnóstico y tratamiento del síndrome mucocutáneo linfonodular (síndrome de Kawasaki). Guía de Práctica Clínica CENETEC. 2010. Disponible en: http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/395_IMSS_10_Kawasaki/EyR_IMSS_395_10.pdf

  4. Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, Newburger JW et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2006; 114(24): 2710-2738.

  5. Fukazawa R. Long-term prognosis of Kawasaki disease: increased cardiovascular risk? Curr Opin Pediatr. 2010; 22(5): 587-592.

  6. Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RS. Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics. 2005; 116(6): e760-e766.

  7. Burns JC, Glodé MP. Kawasaki syndrome. Lancet. 2004; 364(9433): 533-544.

  8. Senzaki H. Long-term outcome of Kawasaki disease. Circulation. 2008; 118(25): 2763-2772.

  9. Kuo HC, Yang KD, Chang WC, Ger LP, Hsieh KS. Kawasaki disease: an update on diagnosis and treatment. Pediatr Neonatol. 2012; 53(1): 4-11.

  10. Cho HJ, Yang SI, Kim KH, Kim JN, Kil HR. Cardiovascular risk factors of early atherosclerosis in school-aged children after Kawasaki disease. Korean J Pediatr. 2014; 57(5): 217-221.

  11. Chen X, Zhao ZW, Li L, Chen XJ, Xu H, Lou JT et al. Hypercoagulation and elevation of blood triglycerides are characteristics of Kawasaki disease. Lipids Health Dis. 2015; 14: 166.

  12. Silva AA, Maeno Y, Hashmi A, Smallhorn JF, Silverman ED, McCrindle BW: Cardiovascular risk factors after Kawasaki disease: a case-control study. J Pediatr. 2001; 138(3): 400-405.

  13. Garg J, Krishnamoorthy P, Palaniswamy C, Paudel R, Chatterjee S, Ahmad H et al. Prevalence and predictors of coronary artery disease in adults with Kawasaki disease. Cardiol Young. 2015; 25(6): 1124-1129.

  14. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004; 114(6): 1708-1733.




2020     |     www.medigraphic.com